Literature DB >> 11355935

Flasks, fibres and flanks--pre-clinical tumour models for predicting clinical antitumour activity.

D R Newell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11355935      PMCID： PMC2363634          DOI： 10.1054/bjoc.2001.1797

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.

Authors:  W Voigt; T Kegel; M Weiss; T Mueller; H Simon; H J Schmoll
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

Review 2.  Antibody Drug Conjugates: Preclinical Considerations.

Authors:  Gadi G Bornstein
Journal:  AAPS J       Date:  2015-02-28       Impact factor: 4.009

Review 3.  Novel treatments for anaplastic thyroid carcinoma.

Authors:  Silvia Martina Ferrari; Giusy Elia; Francesca Ragusa; Ilaria Ruffilli; Concettina La Motta; Sabrina Rosaria Paparo; Armando Patrizio; Roberto Vita; Salvatore Benvenga; Gabriele Materazzi; Poupak Fallahi; Alessandro Antonelli
Journal:  Gland Surg       Date:  2020-01

4.  Antitumor efficacy testing in rodents.

Authors:  Melinda G Hollingshead
Journal:  J Natl Cancer Inst       Date:  2008-10-28       Impact factor: 13.506

5.  Personalization of targeted therapy in advanced thyroid cancer.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Valeria Mazzi; Roberto Vita; Salvatore Benvenga; Alessandro Antonelli
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

Review 6.  New therapies for dedifferentiated papillary thyroid cancer.

Authors:  Poupak Fallahi; Valeria Mazzi; Roberto Vita; Silvia Martina Ferrari; Gabriele Materazzi; David Galleri; Salvatore Benvenga; Paolo Miccoli; Alessandro Antonelli
Journal:  Int J Mol Sci       Date:  2015-03-17       Impact factor: 5.923

7.  Establishment and characterization of novel human primary endometrial cancer cell line (ZJB-ENC1) and its genomic characteristic.

Authors:  Xiaozhen Liu; Zhuozhuo Ren; Yu Xu; Wei Sun; Yongfeng Li; Xinmiao Rui; Dafei Xie; Xuli Meng; Zhiguo Zheng
Journal:  J Cancer       Date:  2019-10-20       Impact factor: 4.207
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.